Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
5
VanEck Oil Services ETF
OIH
No Data
Olema Maintained at Buy as Differentiated Pipeline and Robust Trial Strategy Support Unchanged $24 Price Target
Olema Investors Back Board, Pay and Auditor Decisions
J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating
Wall Street Analysts Are Bullish on Top Healthcare Picks
LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $24
Analysts Offer Insights on Healthcare Companies: Olema Pharmaceuticals (OLMA), Jade Biosciences (JBIO) and Oculis Holding (OCS)